Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02227446 · ClinicalTrials.gov registry record · Phase 3
Local Antibiotic Therapy to Reduce Infection After Operative Treatment of Fractures at High Risk of Infection: A Multicenter Randomized, Controlled Trial (VANCO)
A Phase 3 study, sponsored by Major Extremity Trauma Research Consortium.
- Completed
- Registry status
- Phase 3
- Development phase
- 1,036
- Enrollment target
NCT02227446 is a Phase 3 study that has completed, run by Major Extremity Trauma Research Consortium. The registered enrollment target is 1,036 participants.
The verdict
NCT02227446, a Phase 3 study, has completed, sponsored by Major Extremity Trauma Research Consortium.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 1,036 participants
- Enrollment target
Study Summary
The Vancomycin Study is a multi-center, prospective randomized controlled trial that will compare the proportion of deep surgical site infections within 6 months in patients treated with local Vancomycin powder compared to those treated without local Vancomycin powder at the time of fracture fixation.
Interventions
- DRUG Vancomycin antibiotic powder
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,036 participants |
| Start Date | 2014-10 |
| Est. Completion | 2019-11 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02227446
The ClinicalTrials.gov registry entry for NCT02227446 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 1,036 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Major Extremity Trauma Research Consortium, which has 30 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Vancomycin antibiotic powder is the first listed.
NCT02227446 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02227446 about?
NCT02227446 is a clinical study titled "Local Antibiotic Therapy to Reduce Infection After Operative Treatment of Fractures at High Risk of Infection: A Multicenter Randomized, Controlled Trial (VANCO)". The Vancomycin Study is a multi-center, prospective randomized controlled trial that will compare the proportion of deep surgical site infections within 6 months in patients treated with local Vancomycin powder compared to those treated without local Vancomycin powder at the time of fracture fixatio...
What is the current status of trial NCT02227446?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 1,036 participants. The study started on 2014-10. Estimated completion is 2019-11.
What interventions are being tested in trial NCT02227446?
The interventions under investigation include: Vancomycin antibiotic powder (DRUG).
Who is sponsoring clinical trial NCT02227446?
This trial is sponsored by Major Extremity Trauma Research Consortium, which has 30 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.